Finance

Beta
Lists
CORONA:NSE
Corona Remedies Ltd
₹1,687.00
-0.79%
(-13.50) 1D
Jun 3, 12:13:35 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for CORONA...
Open
₹1,710.00
High
₹1,730.40
Low
₹1,674.40
Mkt. cap
103.18B
Avg. vol.
40.71K
Volume
5.61K
Dividend
0.59%
Quarterly dividend
₹2.50
Ex-dividend date
Jun 19, 2026
P/E ratio
55.73
52-wk high
₹1,949.40
52-wk low
₹1,336.60
EPS
₹30.27
No. of employees
4K
Open
₹1,710.00
High
₹1,730.40
Low
₹1,674.40
Mkt. cap
103.18B
Avg. vol.
40.71K
Volume
5.61K
Dividend
0.59%
Quarterly dividend
₹2.50
Ex-dividend date
Jun 19, 2026
P/E ratio
55.73
52-wk high
₹1,949.40
52-wk low
₹1,336.60
EPS
₹30.27
No. of employees
4K
News stories
From sources across the web
About Corona Remedies Ltd
CEO-
Employees4.5K
Founded2004
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
3.47B
3.61B
3.42B
3.53B
Cost of goods sold
673.91M
686.50M
602.70M
662.40M
Cost of revenue
673.91M
686.50M
602.70M
662.40M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.24B
1.03B
959.40M
1.07B
Operating expense
2.18B
2.23B
2.08B
2.35B
Total operating expenses
2.86B
2.92B
2.69B
3.01B
Operating income
610.30M
692.70M
737.10M
517.30M
Other non operating income
2.79M
22.70M
22.40M
41.10M
EBT including unusual items
606.93M
697.80M
552.10M
547.40M
EBT excluding unusual items
608.38M
697.80M
743.10M
547.40M
Income tax expense
144.97M
174.60M
139.40M
94.10M
Effective tax rate
23.89%
25.02%
25.25%
17.19%
Other operating expenses
855.24M
1.11B
1.03B
1.18B
Net income
461.96M
523.20M
412.70M
453.30M
Net profit margin
13.33%
14.49%
12.05%
12.84%
Earnings per share
-
-
-
7.41
Interest and investment income
14.57M
-
-
-
Interest expense
-19.37M
-19.30M
-16.60M
-13.80M
Net interest expenses
-4.80M
-19.30M
-16.60M
-13.80M
Depreciation and amortization charges
89.18M
92.00M
94.50M
102.90M
EBITDA
690.04M
794.16M
838.56M
611.98M
Gain or loss from assets sale
1.69M
2.61M
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more